What is Disc Medicine's AOCI?

Disc Medicine (IRON) reported AOCI of -$571K in Q1 2026.

How has Disc Medicine's AOCI changed year-over-year?

Disc Medicine's AOCI decreased by 206.7% year-over-year, from $535K to -$571K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Disc Medicine IRON AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Protagonist TherapeuticsPTGX

-$269K-416%

Agios PharmaceuticalsAGIO

-$314K-186%

Beam TherapeuticsBEAM

-$1.07M-769%

Travere Therapeutics, Inc.TVTX

-$1.06M-26.0%

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's AOCI?: Disc Medicine (IRON) reported AOCI of -$571K in Q1 2026.
How has Disc Medicine's AOCI changed year-over-year?: Disc Medicine's AOCI decreased by 206.7% year-over-year, from $535K to -$571K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.